New Drug Approved for Preventing RSV in Newborns, Tots
(MedPage Today) -- The FDA approved nirsevimab (Beyfortus) on Monday for preventing respiratory syncytial virus (RSV)-related lower respiratory tract infections in infants and very young children.
Delivered as a single intramuscular injection...
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news